|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-28
|
|
pubmed:abstractText |
It is unknown whether anastrozole (Ana) is superior to tamoxifen (Tam) with regard to local control after breast-conserving surgery without radiotherapy (RT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1791-7530
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
367-71
|
|
pubmed:meshHeading |
pubmed-meshheading:21273625-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21273625-Breast Neoplasms,
pubmed-meshheading:21273625-Cohort Studies,
pubmed-meshheading:21273625-Combined Modality Therapy,
pubmed-meshheading:21273625-Female,
pubmed-meshheading:21273625-Follow-Up Studies,
pubmed-meshheading:21273625-Humans,
pubmed-meshheading:21273625-Mastectomy, Segmental,
pubmed-meshheading:21273625-Middle Aged,
pubmed-meshheading:21273625-Neoplasm Recurrence, Local,
pubmed-meshheading:21273625-Neoplasm Staging,
pubmed-meshheading:21273625-Nitriles,
pubmed-meshheading:21273625-Radiotherapy Dosage,
pubmed-meshheading:21273625-Retrospective Studies,
pubmed-meshheading:21273625-Survival Rate,
pubmed-meshheading:21273625-Tamoxifen,
pubmed-meshheading:21273625-Treatment Outcome,
pubmed-meshheading:21273625-Triazoles
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Risk of Ipsilateral breast tumor recurrence in patients treated with Tamoxifen or Anastrozole following breast-conserving surgery with or without radiotherapy.
|
|
pubmed:affiliation |
Department of Breast and Endocrine Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan. isitobi-ma@mc.pref.osaka.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
